U.S. prescription drug spending increased 12.7% to $915.2 billion in 2025 and is projected to exceed $1 trillion in 2026, continuing to outpace other countries and drive healthcare costs higher, according to an April 29 report from the American Society…
Pharmacy
For three decades, hospitals and healthcare systems in the 340B Drug Pricing Program have operated with a common purpose: serve vulnerable communities and stretch scarce federal resources while managing rising costs. But as scrutiny of the program has intensified, compliance…
Active drug shortages in the U.S. reached 223 in the first quarter of 2026, increasing for the second consecutive quarter, according to an April report from the American Society of Health-System Pharmacists. That upward trend comes as global supply risks…
A group of leaders from New York City-based Memorial Sloan Kettering Cancer Center, Boston-based Massachusetts General Hospital and Stanford (Calif.) University are calling for academic medical centers to rethink their well-established model of drug discovery and development to stay competitive…
Novartis CEO Vas Narasimhan, MD, said the effects of President Donald Trump’s most favored nation drug pricing policy will become more pronounced over the next 18 months, according to an April 28 report from CNBC. The policy, which ties U.S.…
Advertisement
The FDA’s Center for Drug Evaluation and Research has proposed withdrawing approval of Tavneos (avacopan) after determining the drug has not been shown to be effective for its approved use. The agency said new information revealed unblinded study personnel manipulated…
Pharmacy technician shortages remain one of the most persistent operational challenges facing hospitals, but leaders say the problem extends beyond wage competition. While higher pay from large retailers continues to draw talent away from health systems, pharmacy executives point to…
The Utah Medical Licensing Board has called for the suspension of an AI pilot program that automates prescription renewals. The program, launched through an agreement between the state of Utah and Doctronic, a reportedly free and anonymous online AI platform…
CenterWell, Humana’s pharmacy branch, is collaborating with Mark Cuban’s Cost Plus Drug Co. for an employer-based program, according to an April 27 news release. CenterWell will use Cost Plus Drugs’ SwiftyRx, a digital pharmacy software-as-a-service solution, for medication order intake.…
Johnson & Johnson will begin marketing four prescription drugs on the Trump administration’s TrumpRx website, according to an April 24 report from CBS News. The drugs include metformin, metformin extended release, Invokana and Xarelto. Pricing on the platform shows Invokana…